Amundi Increases Stake in Spotify Technology Stock
- Reports
- 2
- Developments
- 2
- Repetition
- 0%
New informationRepeats or wire copies
What happened
Amundi increased its financial stake in Spotify Technology during the first quarter of the year. The firm purchased an additional 183,994 shares, bringing its total ownership to 1,104,484 shares, valued at $535,575,000 at the end of the reporting period. Other large investors, including Janus Henderson Group PLC and Tiger Global Management LLC, also increased their positions in Spotify Technology during the first quarter.
From tickerreport.com
Why it matters
The increase in institutional ownership by Amundi and other investors suggests confidence in Spotify Technology. This type of institutional buying activity can signal positive sentiment, potentially boosting the company's valuation.
From tickerreport.com
Who's involved
- AmundiFrench subsidiary that increased its investment stake in Spotify stock
- Spotify TechnologyLuxembourgish holding company whose stock Amundi increased its financial stake in
Who could feel it
Possible knock-on effectsThese are possibilities Brind reasoned out, not predictions, and not advice. Most are not stated in any report.
- Spotify TechnologySpeculative
Spotify Technology might see its valuation increase due to growing institutional ownership.
How it developed
Newest first. Tap a step to see who reported it.Nippon Life increased Spotify holdings; Spotify also plans a 2027 AI remix service.1 source
Amundi made a new investment in Spotify stock.1 source
Keep exploring
The entities involved
-
Amundi
French subsidiary jointly created by Crédit Agricole and Société Générale
-
Spotify Technology
Luxembourgish holding company
Nothing else this week.
Related events
- Amundi increased its stock holdings in Apple Inc. on October 20, 2026.
- Amundi increased its stake in Cummins stock on October 8, 2026.
- Amundi increased its investment stake in Tesla shares on October 6, 2026.
- Amundi raised its holdings in Mastercard stock on October 31, 2026.
- Truist Financial raised its target price and Amundi increased its position in Harmony Biosciences shares.